Two new developments for cancer treatment from Russian scientists

Russian scientists have developed two new cancer treatments: a chemotherapy drug designed to reduce cardiac side effects, targeted for release in 2029, and a vaccine called CaTeVac aimed at multiple cancer types, planned for availability in 2027. Experts caution that both methods still require comprehensive clinical trials to confirm their efficacy and safety. The announcements signal Russia's push to expand its oncology pipeline, though neither candidate has yet cleared the regulatory milestones that would validate the early timelines. Watchers should track trial design and enrollment data, which will determine whether the 2027 and 2029 targets hold.